Warning: Illegal string offset 'font_awesome' in /home/webadmin/websites/competitionpolicyinternational.com/releases/20190905/wp-content/plugins/td-composer/includes/tdc_main.php on line 413

Notice: Array to string conversion in /home/webadmin/websites/competitionpolicyinternational.com/releases/20190905/wp-content/plugins/td-composer/includes/tdc_main.php on line 413
Home Tags Reverse Payment Settlements

Tag: Reverse Payment Settlements

Consumer Welfare In Competition And Intellectual Property Law

Herbert Hovenkamp, Dec 20, 2013 Whether antitrust policy should pursue a goal of “general welfare” or “consumer welfare” has been debated for decades. The academic...

Evaluating the Size of Reverse Payments In Light of the Supreme...

James Langenfeld, Dec 30, 2013 Patent settlement agreements that involve payments from brand-name drug manufacturers to generic drug manufacturers (so called "reverse payments" or "pay...

When Does Interpretation Become Rewriting? The FTC Runs With the Actavis...

Kent Bernard, Sep 30, 2013 A Hatch-Waxman settlement case finally reached the Supreme Court, and when it did the Court in FTC v. Actavis rejected both...

European Commission Enforcement in the Pharmaceutical Sector: Less Than Expected? The...

Sean-Paul Brankin, Jul 27, 2012 On July 6, 2011, the European Commission closed the case file in itsBoehringer/Almirall investigation. It did so without a formal...

Cervantes Sequel: The FTC’s Quest to End Pay-for-Delay Pharma Settlements

Anne Layne-Farrar, Jun 27, 2012 We are drawing close to the thirtieth anniversary of the Drug Price Competition and Patent Term Restoration Act, better known...

Pharmaceutical Patent Settlements – A Presumption in Reverse

This article is part of a Chronicle. See more from this Chronicle Patrick Harrison, Kristina Nordlander, Aug 13, 2009 On July 8, 2009, the European Commission's...

News